This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lesko, S. M.
Right arrow Articles by Mitchell, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lesko, S. M.
Right arrow Articles by Mitchell, A. A.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Varicella-Zoster Infections
Non-Group A or B Streptococcal and...
Group A Streptococcal Infections
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 107 No. 5 May 2001, pp. 1108-1115

Invasive Group A Streptococcal Infection and Nonsteroidal Antiinflammatory Drug Use Among Children With Primary Varicella

Received Jun 29, 2000; accepted Oct 5, 2000.

Samuel M. Lesko*, Katherine L. O'BrienDagger , §, parallel , Benjamin SchwartzDagger , , Richard Vezina*, and Allen A. Mitchell*

From the * Slone Epidemiology Unit, School of Public Health, Boston University School of Medicine, Brookline, Massachusetts; Dagger  Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; § Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia; parallel  Center for American Indian and Alaskan Native Health, Johns Hopkins University School of Public Health, Baltimore, Maryland; and the  National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia.

Objectives.  To test the hypothesis that nonsteroidal antiinflammatory drug use increases the risk of necrotizing soft tissue infections and, secondarily, all invasive group A streptococcal (GAS) infections in children with primary varicella infection.

Methods.  We conducted a prospective, multicenter case-control study among children <19 years old. Cases were children hospitalized with primary varicella complicated by invasive GAS infection or necrotizing soft tissue infection identified by a network of 45 pediatric infectious disease specialists located throughout the United States. Controls were children with uncomplicated primary varicella residing in the same communities as the cases. Data on medical history, clinical features of the varicella infection, signs and symptoms of infectious complications, and medication use were collected by structured telephone interviews. Univariate and multivariate matched odds ratios were calculated using conditional logistic regression.

Results.  Between June 1996 and September 1998, 52 cases of invasive GAS infection, including 21 with necrotizing soft tissue infection, and 172 controls with uncomplicated primary varicella were enrolled. Risk of invasive GAS infection was increased among children who were nonwhite (multivariate odds ratio [OR] 3.8, 95% confidence interval [CI]: 1.4-11), living in low-income households (OR 5.1, 95% CI: 1.7-15), exposed to varicella at home (OR 6.4, 95% CI: 2.6-16), or had a persistent high fever (OR 9.6, 95% CI: 2.8-33). Antipyretic regimen was associated with several measures of varicella illness severity among the controls. The risk of necrotizing soft tissue infection was not associated with the use of ibuprofen before the development of signs or symptoms of this complication (OR 1.3, 95% CI: 0.33-5.3). Risk of any invasive GAS infection was increased among children who had received ibuprofen (OR 3.9, 95% CI: 1.3-12), but not acetaminophen (OR 1.2, 95% CI: 0.50-3.0). However, there was no evidence of increasing risk with increasing duration of ibuprofen use. Subgroup analyses revealed that the risk of invasive GAS infection was increased only among children who had received both acetaminophen and ibuprofen.

Conclusions.  These data do not support the hypothesis that nonsteroidal antiinflammatory drugs, or ibuprofen in particular, increase the risk of necrotizing GAS infections. A statistically significant association was observed between nonnecrotizing invasive GAS infection and ibuprofen use; however, because of potential confounding, the meaning of this unexpected result is unclear. Nonetheless, these data suggest that parents use ibuprofen or ibuprofen together with acetaminophen to treat high fever and severe illness, which seems to identify children at high risk for invasive GAS infection.  Key words:  children, confounding, group A streptococcus, ibuprofen, necrotizing infection, NSAIDs, varicella.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
BMJHome page
M. Nabulsi
Is combining or alternating antipyretic therapy more beneficial than monotherapy for febrile children?
BMJ, October 1, 2009; 339(oct01_2): b3540 - b3540.
[Full Text]


Home page
BMJHome page
C. A C. Ospina and A. Salcedo
Ibuprofen increases soft tissue infections in children
BMJ, September 23, 2008; 337(sep23_2): a1767 - a1767.
[Full Text]


Home page
CLIN PEDIATRHome page
A. M. Burnett and J. B. Domachowske
Therapeutic Considerations for Children With Invasive Group A Streptococcal Infections: A Case Series Report and Review of the Literature
Clinical Pediatrics, July 1, 2007; 46(6): 550 - 555.
[PDF]


Home page
Pediatr. Rev.Home page
R. English
Varicella
Pediatr. Rev., November 1, 2003; 24(11): 372 - 379.
[Full Text] [PDF]